3
Announcements
Trials
Browse
Landscape
Status
No longer available
1
Sponsor Class
INDUSTRY
1
Study Type
Expanded_access
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Thoracic Neoplasms
1
Respiratory Tract Neoplasms
1
Respiratory Tract Diseases
1
Neoplasms by Site
1
Neoplasms
1
Lung Neoplasms
1
Lung Diseases
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Bronchogenic
1
Carcinoma
1
Interventions
Crizotinib
2
Bone Marrow Transplantation
2
3-Iodobenzylguanidine
2
vorasidenib
1
tucatinib
1
tovorafenib
1
tazemetostat
1
taletrectinib
1
olaparib
1
nirogacestat
1
glucarpidase
1
enzalutamide
1
denileukin diftitox
1
copanlisib
1
balstilimab
1
atezolizumab
1
adagrasib
1
Proton Pump Inhibitors
1
Peripheral Blood Stem Cell Transplantation
1
Nivolumab
1
LY3023414
1
Hydrocortisone
1
Carboxypeptidases
1
Antibodies, Bispecific
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Expanded_access
×
Neoplasms
×
taletrectinib
×
Clear all
NCT06841874
2025-12-24
Tale EAP
Nuvation Bio Inc.
No longer available